These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8453952)

  • 1. Efficacy and safety of zonisamide: results of a multicenter study.
    Leppik IE; Willmore LJ; Homan RW; Fromm G; Oommen KJ; Penry JK; Sackellares JC; Smith DB; Lesser RP; Wallace JD
    Epilepsy Res; 1993 Feb; 14(2):165-73. PubMed ID: 8453952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.
    Schmidt D; Jacob R; Loiseau P; Deisenhammer E; Klinger D; Despland A; Egli M; Bauer G; Stenzel E; Blankenhorn V
    Epilepsy Res; 1993 May; 15(1):67-73. PubMed ID: 8325280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and monitoring of patients treated with zonisamide: the OZONE study.
    Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B
    Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide in the management of epilepsy in the elderly.
    Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V
    Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients.
    Heo K; Lee BI; Yi SD; Cho YW; Shin DJ; Song HK; Kim OJ; Park SP; Kim SE; Kim SH; Lee JH; Kim KS; Lee SJ
    Seizure; 2012 Apr; 21(3):188-93. PubMed ID: 22226572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide in epilepsy: a pilot study.
    Wilensky AJ; Friel PN; Ojemann LM; Dodrill CB; McCormick KB; Levy RH
    Epilepsia; 1985; 26(3):212-20. PubMed ID: 4006880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term retention rate of zonisamide in patients with epilepsy: an observational study.
    Kim DW; Choi K; Moon HS; Oh J
    Clin Neuropharmacol; 2014; 37(5):133-5. PubMed ID: 25229169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.
    Kothare SV; Kaleyias J
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):493-506. PubMed ID: 18433351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy].
    Villanueva V; Serrano-Castro PJ
    Rev Neurol; 2013 Apr; 56(8):429-38. PubMed ID: 23568686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide in pediatric epilepsy: review of the Japanese experience.
    Glauser TA; Pellock JM
    J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide therapy for refractory idiopathic epilepsy in dogs.
    Dewey CW; Guiliano R; Boothe DM; Berg JM; Kortz GD; Joseph RJ; Budsberg SC
    J Am Anim Hosp Assoc; 2004; 40(4):285-91. PubMed ID: 15238558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide and renal calculi in patients with epilepsy: how big an issue?
    Wroe S
    Curr Med Res Opin; 2007 Aug; 23(8):1765-73. PubMed ID: 17594758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.